Sides David William's Form 4 filing
Nextgen Healthcare, Inc. (NXGN) · filed Nov 30, 2021
- Accession no.
- 0001209191-21-067174
- Filed
- Nov 30, 2021
- Trade date
- Nov 30, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $101.5K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sides David WilliamCIK 0001619248 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2021 | Common Stock | PPurchaseAcquired | +6,500 | $15.62F1 | +$101,530 | 647,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.61 to $15.63. Full information regarding the number of shares purchased at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
Referenced by the price of 1 transaction in Table I.